Evidence map›Paper›PMID 34149804›Full record

ArticleFrontiers in genetics2021

Effect of the Expression of

Sergey Nikulin, Galina Zakharova, Andrey Poloznikov, Maria Raigorodskaya, Daniel Wicklein, Udo Schumacher, Stepan Nersisyan, Jonas Bergquist, Georgy Bakalkin, Lidiia Astakhova and 1 more

Abstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. ELOVL5 Regulates Ferroptosis in Breast Cancer Cells.Doklady. Biochemistry and biophysics · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Frontiers in molecular biosciences · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sergey NikulinFaculty of Biology and Biotechnologies, National Research University Higher School of Economics, Moscow, Russia.
Galina ZakharovaScientific Research Centre Bioclinicum, Moscow, Russia.
Andrey PoloznikovFaculty of Biology and Biotechnologies, National Research University Higher School of Economics, Moscow, Russia.
Maria RaigorodskayaFaculty of Biology and Biotechnologies, National Research University Higher School of Economics, Moscow, Russia.
Daniel WickleinInstitute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Udo SchumacherInstitute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stepan NersisyanFaculty of Biology and Biotechnologies, National Research University Higher School of Economics, Moscow, Russia.
Jonas BergquistDepartment of Chemistry - BMC, Uppsala University, Uppsala, Sweden.
Georgy BakalkinDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Lidiia AstakhovaScientific Research Centre Bioclinicum, Moscow, Russia.
Alexander TonevitskyFaculty of Biology and Biotechnologies, National Research University Higher School of Economics, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is the leading cause of death from malignant neoplasms among women worldwide, and metastatic BC presents the biggest problems for treatment. Previously, it was shown that lower expression of

Indexed as

breast cancercell–cell contactsELOVL5IGFBP6matrix metalloproteinasesMDA-MB-231

Identifiers

PMID34149804
PMCPMC8206645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.